Mechanisms of decreased vascular function with aging

Hypertension

Volumn 53, Issue 6, 2009, Pages 900-902

  Barac, Ana ^a   Panza, Julio A ^a  

^a WASHINGTON HOSPITAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PROSTACYCLIN; PROSTAGLANDIN SYNTHASE; REACTIVE OXYGEN METABOLITE; NITRIC OXIDE SYNTHASE;

AGING; ATHEROSCLEROSIS; ATHEROSCLEROTIC CARDIOVASCULAR DISEASE; BLOOD VESSEL TONE; BRACHIAL ARTERY; CARDIOVASCULAR FUNCTION; CELL SURFACE; DISEASE COURSE; EDITORIAL; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVITY; FATTY ACID SYNTHESIS; GENE EXPRESSION; HUMAN; HYPERTENSION; MORTALITY; NONHUMAN; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK FACTOR; SMOOTH MUSCLE FIBER; AGE; AGED; CARDIOVASCULAR DISEASE; FEMALE; GERIATRIC ASSESSMENT; MALE; METABOLISM; NOTE; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PHYSIOLOGY; PROGNOSIS; RISK ASSESSMENT; VASCULAR ENDOTHELIUM;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; FEMALE; GERIATRIC ASSESSMENT; HUMANS; MALE; NITRIC OXIDE SYNTHASE; PERIPHERAL VASCULAR DISEASES; PROGNOSIS; RISK ASSESSMENT;

EID: 67049156700     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.132308     Document Type: Editorial

References (10)

1. Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res. 2005;66:286-294.
2. Nicholson WT, Vaa B, Hesse C, Eisenach JH, Joyner MJ. Aging is associated with reduced prostacyclin-mediated dilation in the human forearm. Hypertension. 2009;53:973-978.
3. Mitchell JA, Ali F, Bailey L, Moreno L, Harrington LS. Role of nitric oxide and prostacyclin as vasoactive hormones released by the endothe-lium. Exp Physiol. 2008;93:141-147.
4. Mollace V, Muscoli C, Masini E, Cuzzocrea S, Salvemini D. Modulation of prostaglandin biosynthesis by nitric oxide and nitric oxide donors. Pharmacol Rev. 2005;57:217-252.
5. Niwano K, Arai M, Tomaru K, Uchiyama T, Ohyama Y, Kurabayashi M. Transcriptional stimulation of the eNOS gene by the stable prostacyclin analogue beraprost is mediated through cAMP-responsive element in vascular endothelial cells: close link between PGI2 signal and NO pathways. Circ Res. 2003;93:523-530.
6. Campia U, Choucair WK, Bryant MB, Quyyumi AA, Cardillo C, Panza JA. Role of cyclooxygenase products in the regulation of vascular tone and in the endothelial vasodilator function of normal, hypertensive, and hypercholesterolemic humans. Am J Cardiol. 2002;89:286-290.
7. Taddei S, Virdis A, Mattei P, Ghiadoni L, Fasolo CB, Sudano I, Salvetti A. Hypertension causes premature aging of endothelial function in humans. Hypertension. 1997;29:736-743.
8. Schror K. Cyclooxygenase-2-derived prostaglandin F2alpha: an endothelium-derived contractile factor acting independently of other endothelium-derived contractile factors via vascular thromboxane receptors. Circ Res. 2009;104: 141-143.
9. Vanhoutte PM, Tang EH. Endothelium-dependent contractions: when a good guy turns bad! J Physiol. 2008;586:5295-5304.
10. Bhatt DL. NSAIDS and the risk of myocardial infarction: do they help or harm? Eur Heart J. 2006;27:1635-1636.